A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stability - PubMed (original) (raw)
A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stability
Jing Fang et al. J Cell Physiol. 2006 Nov.
Abstract
Human double minute 2 (HDM2) is an oncoprotein overexpressed in many human cancers. HDM2 expression is regulated at multiple levels in cells. Phosphorylation of HDM2 plays an important role in its post-translational regulation. In this study, we have shown that the phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, and the mammalian target of rapamycin (mTOR) inhibitor, rapamycin, have similar effects on the inhibition of HDM2 phosphorylation and protein turnover. Rapamycin inhibited p70S6K1, but not AKT activation, indicating that rapamycin affects HDM2 phosphorylation via an AKT-independent mechanism. Rapamycin also decreased HDM2 protein stability. Knockdown of p70S6K1 by a p70S6K1 siRNA resulted in the inhibition of HDM2 phosphorylation and a decrease in HDM2 protein turnover. Overexpression of p70S6K1 enhanced HDM2 phosphorylation and led to an increase in HDM2 protein turnover. Our results suggest that p70S6K1 regulates turnover of HDM2 protein for cancer development.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
- G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N, Flynn DC, Zhang Z, Zhong XS, Walker V, Liu KJ, Shi X, Jiang BH. Gao N, et al. Am J Physiol Cell Physiol. 2004 Aug;287(2):C281-91. doi: 10.1152/ajpcell.00422.2003. Epub 2004 Mar 17. Am J Physiol Cell Physiol. 2004. PMID: 15028555 - Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling.
Skinner HD, Zheng JZ, Fang J, Agani F, Jiang BH. Skinner HD, et al. J Biol Chem. 2004 Oct 29;279(44):45643-51. doi: 10.1074/jbc.M404097200. Epub 2004 Aug 26. J Biol Chem. 2004. PMID: 15337760 - Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y, Takeuchi T, Koeffler HP, Taguchi H. Ikezoe T, et al. Leuk Res. 2007 May;31(5):673-82. doi: 10.1016/j.leukres.2006.08.001. Epub 2006 Sep 27. Leuk Res. 2007. PMID: 17007924 - Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, Khuri FR. Sun SY, et al. Cancer Res. 2005 Aug 15;65(16):7052-8. doi: 10.1158/0008-5472.CAN-05-0917. Cancer Res. 2005. PMID: 16103051 - Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. focus on "The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation".
Lucchesi PA. Lucchesi PA. Am J Physiol Cell Physiol. 2004 Mar;286(3):C480-1. doi: 10.1152/ajpcell.00526.2003. Am J Physiol Cell Physiol. 2004. PMID: 14761882 Review. No abstract available.
Cited by
- S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
Shen H, Wang GC, Li X, Ge X, Wang M, Shi ZM, Bhardwaj V, Wang ZX, Zinner RG, Peiper SC, Aplin AE, Jiang BH, He J. Shen H, et al. Oncogene. 2020 Dec;39(49):7181-7195. doi: 10.1038/s41388-020-01497-4. Epub 2020 Oct 9. Oncogene. 2020. PMID: 33037411 Free PMC article. - β1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells.
Cui C, Chen X, Liu Y, Cao B, Xing Y, Liu C, Yang F, Li Y, Yang T, Hua L, Tian M, Wei Y, Gong Y, Jiang J. Cui C, et al. J Biol Chem. 2018 Feb 9;293(6):2219-2230. doi: 10.1074/jbc.RA117.000682. Epub 2017 Dec 21. J Biol Chem. 2018. PMID: 29269413 Free PMC article. - Inhibition of p70S6K1 Activation by Pdcd4 Overcomes the Resistance to an IGF-1R/IR Inhibitor in Colon Carcinoma Cells.
Zhang Y, Wang Q, Chen L, Yang HS. Zhang Y, et al. Mol Cancer Ther. 2015 Mar;14(3):799-809. doi: 10.1158/1535-7163.MCT-14-0648. Epub 2015 Jan 8. Mol Cancer Ther. 2015. PMID: 25573956 Free PMC article. - mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions.
Showkat M, Beigh MA, Andrabi KI. Showkat M, et al. Mol Biol Int. 2014;2014:686984. doi: 10.1155/2014/686984. Epub 2014 Nov 20. Mol Biol Int. 2014. PMID: 25505994 Free PMC article. Review. - The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design.
Couty S, Westwood IM, Kalusa A, Cano C, Travers J, Boxall K, Chow CL, Burns S, Schmitt J, Pickard L, Barillari C, McAndrew PC, Clarke PA, Linardopoulos S, Griffin RJ, Aherne GW, Raynaud FI, Workman P, Jones K, van Montfort RL. Couty S, et al. Oncotarget. 2013 Oct;4(10):1647-61. doi: 10.18632/oncotarget.1255. Oncotarget. 2013. PMID: 24072592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous